MedTrace Logo

Medication Adherence Research in COPD Patients

NCT03174704 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 314

Last updated 2023-05-11

No results posted yet for this study

Summary

Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death, affects over 24 million people in the US and is the leading cause of disability with projected healthcare costs at almost $50 billion. The goal of this study is to identify novel and potentially powerful targets for behavioral interventions in COPD which has been understudied despite its tremendous detrimental impact on overall public health.

Conditions

  • COPD
  • Medication Adherence

Sponsors & Collaborators

Principal Investigators

  • Michelle N Eakin, Ph.D. · Johns Hopkins University

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03174704 on ClinicalTrials.gov